Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

247
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
247

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ASO Visual Abstract: Assessing Response and Outcomes to Modern Multi-Agent Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma.

Annals of surgical oncology·2026
Same author

Assessing Response and Outcomes to Modern Multiagent Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma.

Annals of surgical oncology·2026
Same author

Does neoadjuvant therapy reduce pancreatic fistula after pancreatoduodenectomy and distal pancreatectomy?-a systematic review and meta-analysis.

Hepatobiliary surgery and nutrition·2026
Same author

Acid sphingomyelinase activity regulates in vitro CREB activation in murine primary neurons.

Behavioural brain research·2026
Same author

Zuclopenthixol inhibits residual activity of acid sphingomyelinase in Niemann pick disease type B: a case report with in vitro validation.

Orphanet journal of rare diseases·2026
Same author

Rhinovirus infection promotes suppression of sphingosine and enhanced bacterial infection in cystic fibrosis airways.

The Journal of biological chemistry·2026
Same journal

RETRACTED: Kim et al. The Angiogenesis Inhibitor ALS-L1023 from Lemon-Balm Leaves Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease Through Regulating the Visceral Adipose-Tissue Function. <i>Int. J. Mol. Sci.</i> 2017, <i>18</i>, 846.

International journal of molecular sciences·2026
Same journal

Correction: Mahmud et al. Thymoquinone Attenuates NF-κβ Signalling Activation in Retinal Pigment Epithelium Cells Under AMD-Mimicking Conditions. <i>Int. J. Mol. Sci.</i> 2025, <i>26</i>, 11473.

International journal of molecular sciences·2026
Same journal

Correction: Borovikov et al. The Twisting and Untwisting of Actin and Tropomyosin Filaments Are Involved in the Molecular Mechanisms of Muscle Contraction, and Their Disruption Can Result in Muscle Disorders. <i>Int. J. Mol. Sci</i>. 2025, <i>26</i>, 6705.

International journal of molecular sciences·2026
Same journal

Correction: Molagoda et al. Flavonoid Glycosides from <i>Ziziphus jujuba</i> var. <i>inermis</i> (Bunge) Rehder Seeds Inhibit α-Melanocyte-Stimulating Hormone-Mediated Melanogenesis. <i>Int. J. Mol. Sci.</i> 2021, <i>22</i>, 7701.

International journal of molecular sciences·2026
Same journal

Correction: Guo et al. Integrated Transcriptomic and Metabolomic Analysis Reveals the Molecular Regulatory Mechanism of Flavonoid Biosynthesis in Maize Roots Under Lead Stress. <i>Int. J. Mol. Sci.</i> 2024, <i>25</i>, 6050.

International journal of molecular sciences·2026
Same journal

Correction: Chang et al. Improvement of Carbon Tetrachloride-Induced Acute Hepatic Failure by Transplantation of Induced Pluripotent Stem Cells Without Reprogramming Factor c-Myc. <i>Int. J. Mol. Sci.</i> 2012, <i>13</i>, 3598-3617.

International journal of molecular sciences·2026
See all related articles

Related Experiment Video

Updated: Jul 1, 2025

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
12:27

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors

Published on: June 8, 2022

3.4K

Sphingosine Prevents Rhinoviral Infections.

Judith Lang1, Matthias Soddemann2, Michael J Edwards2

  • 1Department of Immunology, University Clinic, University of Duisburg-Essen, Hufelandstrasse 55, 45122 Essen, Germany.

International Journal of Molecular Sciences
|March 13, 2024
PubMed
Summary
This summary is machine-generated.

Sphingosine effectively prevents rhinovirus infections in human cells and mice by binding to the virus. This lipid treatment shows no adverse effects, offering a potential therapeutic strategy for respiratory viral infections.

Keywords:
adverse effectscommon coldinfectionnoserhinovirussphingosine

More Related Videos

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

16.9K
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

15.7K

Related Experiment Videos

Last Updated: Jul 1, 2025

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
12:27

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors

Published on: June 8, 2022

3.4K
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

16.9K
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

15.7K

Area of Science:

  • Virology and Immunology
  • Biochemistry and Biophysics

Background:

  • Rhinoviral infections account for approximately 50% of upper respiratory tract infections.
  • Novel therapeutic strategies are urgently needed to combat rhinovirus infections.

Purpose of the Study:

  • To investigate the efficacy of sphingosine in preventing rhinovirus infections in vitro and in vivo.
  • To elucidate the mechanism of action of sphingosine against rhinovirus.
  • To assess the safety profile of sphingosine in nasal epithelial cells and mucosa.

Main Methods:

  • In vitro studies using cultured and freshly isolated human cells challenged with minor and major group rhinoviruses.
  • In vivo studies involving intranasal administration of sphingosine to mice before and after rhinovirus infection.
  • Analysis of viral infection in nasal epithelial cells and assessment of cellular toxicity using hemalaun and TUNEL stainings.
  • Characterization of the direct binding interaction between sphingosine and rhinovirus.

Main Results:

  • Sphingosine treatment prevented rhinovirus infections in human nasal epithelial cells.
  • Intranasal sphingosine administration protected mice from rhinovirus infection, even when applied up to 8 hours post-infection.
  • Sphingosine demonstrated no adverse effects on nasal epithelial cells or mucosa.
  • Direct binding of positively charged sphingosine to negatively charged viral molecules was observed, inhibiting infection.

Conclusions:

  • Exogenous sphingosine effectively prevents rhinovirus infections through a biophysical mechanism.
  • Sphingosine presents a promising therapeutic candidate for preventing viral respiratory infections.
  • Further research is warranted to explore its potential against other respiratory viruses and to determine pharmacokinetics.